Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease. (1st October 2020)

• Record Type: Journal Article
• Authors: Feng, Ma; Darabi, Maryam; Tubeuf, Emilie; Canicio, Aurélie; Lhomme, Marie; Frisdal, Eric; Lanfranchi-Lebreton, Sandrine; Matheron, Lucrèce; Rached, Fabiana; Ponnaiah, Maharajah; Serrano, Carlos V; Santos, Raul D; Brites, Fernando; Bolbach, Gerard; Gautier, Emmanuel; Huby, Thierry; Carrie, Alain; Bruckert, Eric; Guerin, Maryse; Couvert, Philippe; Giral, Philippe; Lesnik, Philippe; Le Goff, Wilfried; Guillas, Isabelle; Kontush, Anatol
• Is Part Of: European journal of preventive cardiology. Volume 27:Number 15(2020)
• Page Start: 1606
• Page End: 1616
• Publication Date: 2020-10-01
• Subjects: Lipoprotein lipase -- atherosclerosis -- postprandial lipid metabolism -- apolipoproteins -- chylomicrons -- HDL function -- HDL metabolism -- LCAT -- lipoprotein metabolism -- CETP; Cardiovascular system -- Diseases -- Prevention -- Periodicals; Cardiac patients -- Rehabilitation -- Periodicals; 616.12
• DOI: 10.1177/2047487319894114
• Languages: English
• ISSNs: 2047-4873

Abstract

Abstract : Background: Low concentrations of high-density lipoprotein cholesterol (HDL-C) represent a well-established cardiovascular risk factor. Paradoxically, extremely high HDL-C levels are equally associated with elevated cardiovascular risk, resulting in the U-shape relationship of HDL-C with cardiovascular disease. Mechanisms underlying this association are presently unknown. We hypothesised that the capacity of high-density lipoprotein (HDL) to acquire free cholesterol upon triglyceride-rich lipoprotein (TGRL) lipolysis by lipoprotein lipase underlies the non-linear relationship between HDL-C and cardiovascular risk. Methods: To assess our hypothesis, we developed a novel assay to evaluate the capacity of HDL to acquire free cholesterol (as fluorescent TopFluor® cholesterol) from TGRL upon in vitro lipolysis by lipoprotein lipase. Results: When the assay was applied to several populations markedly differing in plasma HDL-C levels, transfer of free cholesterol was significantly decreased in low HDL-C patients with acute myocardial infarction (−45%) and type 2 diabetes (–25%), and in subjects with extremely high HDL-C of >2.59 mmol/L (>100 mg/dL) (−20%) versus healthy normolipidaemic controls. When these data were combined and plotted against HDL-C concentrations, an inverse U-shape relationship was observed. Consistent with these findings, animal studies revealed that the capacity of HDL to acquire cholesterol upon lipolysis was reduced in low HDL-C apolipoprotein A-I knock-out mice and was negatively correlated with aortic accumulation of [ 3 H]-cholesterol after oral gavage, attesting this functional characteristic as a negative metric of postprandial atherosclerosis. Conclusions: Free cholesterol transfer to HDL upon TGRL lipolysis may underlie the U-shape relationship between HDL-C and cardiovascular disease, linking HDL-C to triglyceride metabolism and atherosclerosis.